Clover Health Investments Corp (NASDAQ: CLOV) on Monday, soared 1.24% from the previous trading day, before settling in for the closing price of $3.23. Within the past 52 weeks, CLOV’s price has moved between $0.61 and $4.71.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 52.25%. The company achieved an average annual earnings per share of 73.20%. With a float of $377.43 million, this company’s outstanding shares have now reached $394.44 million.
The extent of productivity of a business whose workforce counts for 552 workers is very important to gauge. In terms of profitability, gross margin is 33.96%, operating margin of -5.84%, and the pretax margin is -6.21%.
Clover Health Investments Corp (CLOV) Insider and Institutional Ownership
Observing investor behavior towards Healthcare Plans industry stocks is more important than anything else. The insider ownership of Clover Health Investments Corp is 24.68%, while institutional ownership is 16.39%. The most recent insider transaction that took place on Aug 09 ’24, was worth 999,596. In this transaction Director of this company bought 531,700 shares at a rate of $1.88, taking the stock ownership to the 1,409,267 shares. Before that another transaction happened on Jun 17 ’24, when Company’s Director bought 877,567 for $1.14, making the entire transaction worth $1,000,426. This insider now owns 877,567 shares in total.
Clover Health Investments Corp (CLOV) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.04 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 73.20% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 19.10% during the next five years compared to -585.84% drop over the previous five years of trading.
Clover Health Investments Corp (NASDAQ: CLOV) Trading Performance Indicators
Clover Health Investments Corp (CLOV) is currently performing well based on its current performance indicators. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.06.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.19, a number that is poised to hit -0.07 in the next quarter and is forecasted to reach -0.14 in one year’s time.
Technical Analysis of Clover Health Investments Corp (CLOV)
The latest stats from [Clover Health Investments Corp, CLOV] show that its last 5-days average volume of 5.09 million was inferior to 7.72 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 62.22%. Additionally, its Average True Range was 0.17.
During the past 100 days, Clover Health Investments Corp’s (CLOV) raw stochastic average was set at 55.14%, which indicates a significant increase from 54.24% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 35.35% in the past 14 days, which was lower than the 92.35% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.58, while its 200-day Moving Average is $2.13. Now, the first resistance to watch is $3.31. This is followed by the second major resistance level at $3.35. The third major resistance level sits at $3.41. If the price goes on to break the first support level at $3.21, it is likely to go to the next support level at $3.15. The third support level lies at $3.11 if the price breaches the second support level.
Clover Health Investments Corp (NASDAQ: CLOV) Key Stats
Market capitalization of the company is 1.64 billion based on 501,109K outstanding shares. Right now, sales total 2,034 M and income totals -213,360 K. The company made 330,990 K in profit during its latest quarter, and -9,160 K in sales during its previous quarter.
